Aidoc

Aidoc is an enterprise clinical AI vendor focused on inserting machine-generated findings into real hospital workflows. Its aiOS platform is designed as a common operating layer for AI applications, rather than a single radiology model. The vendor’s September 2026 homepage says Aidoc is used by more than 1,600 medical centers worldwide and that its solutions can touch 75% of patients in a health system. Its radiology portfolio automatically analyzes medical imaging, prioritizes suspected urgent findings, activates care teams, and supports follow-up. The site also covers cardiology, neurovascular, and vascular workflows, including coronary artery disease, stroke, brain aneurysm, pulmonary embolism, deep-vein thrombosis, aortic disease, and IVC-filter follow-up.

The practical value is orchestration. aiOS connects applications with existing imaging and clinical systems; Care Coordination routes notifications and context to the appropriate users; Patient Management helps identify, capture, and follow patients over time; and Systems Integrations offers custom configuration with what Aidoc describes as minimal IT lift. The platform can also host vetted third-party algorithms and OEM partners. That architecture distinguishes Aidoc from buying isolated algorithms that each require separate integration, governance, monitoring, and user training. Aidoc cites workflow outcomes including 31% faster time-to-notification for pulmonary embolism and a 34% reduction in door-to-puncture time for stroke. Those figures are useful signals, but a hospital should inspect the linked study design, population, baseline, and local reproducibility before including them in an ROI model.

Start with one measurable pathway, such as suspected PE triage. Track sensitivity, specificity, false alerts, notification-to-acknowledgment time, treatment time, follow-up completion, and clinician override rates. Run a silent validation period before alerts affect care, document escalation ownership, and test downtime procedures. Aidoc should complement—not replace—radiologist and clinician judgment. Buyers comparing healthcare AI can review Abridge for clinical documentation and Notable Health for administrative automation. Our vertical AI guide explains why domain-specific workflow depth matters, while AI agent governance covers accountability and audit controls.

Aidoc’s strengths are its multi-specialty footprint, centralized platform, installed hospital base, and ability to carry a finding into care coordination rather than stopping at detection. Its constraints include a significant implementation program, dependence on PACS/EHR interfaces and clean identity matching, alert-fatigue risk, jurisdiction-specific regulatory status, and clinical liability that remains with healthcare professionals. No public numeric price appeared on the homepage or pricing route. Pricing is therefore recorded as a custom enterprise quote, and buyers should request algorithm-by-algorithm licensing, implementation, interface, support, training, renewal, and expansion costs. No first-party MCP support was verified. Aidoc is best suited to health systems ready to govern a portfolio of clinical AI applications, not clinics looking for a self-serve subscription.